期刊文献+

食管鳞癌患者血清VEGF、Endostatin水平变化及意义 被引量:1

下载PDF
导出
摘要 目的观察食管鳞癌患者血清血管内皮生长因子(VEGF)和内皮抑素(Endostatin)的水平变化,并探讨其意义。方法采用ELISA法检测126例食管鳞癌患者和14例健康对照者血清VEGF及Endostatin。结果食管鳞癌患者血清VEGF为(20.68±3.09)μg/L、Endostatin为(4.96±1.72)μg/L,健康对照者分别为(3.82±6.28)μg/L(、1.60±0.37)μg/L,两组相比,P均<0.05。食管鳞癌患者血清中VEGF、Endostatin水平与肿瘤分化程度、TNM分期、肿瘤直径、淋巴结转移有关(P均<0.01),其血清VEGF与Endostatin的水平呈正相关(r=0.594,P<0.01)。结论食管鳞癌患者血清VEGF、Endostatin水平升高,可作为食管鳞癌恶性程度及肿瘤负荷的预测指标。
出处 《山东医药》 CAS 北大核心 2011年第42期70-71,共2页 Shandong Medical Journal
基金 江苏省重大科技与自主创新研究基金资助项目(BE20101016)
  • 相关文献

参考文献8

  • 1Moschos SJ, Odoux C, Land SR, et al. Endostatin plus interferonalpha 2b therapy for metastatic melanoma: a novel combination of antiangiogenie and immunomodulatory agents [ J]. Melanoma Res, 2007,17(3) :193-200.
  • 2Hofstetter W, Correa AM, Bekele N, et al. Proposed modification of nodal status in AJCC esophageal cancer staging system [ J ]. Ann Thorac Surg, 2007,84 (2) :365-373.
  • 3Bj~rndahl MA, Cao R, Burton JB, et al. Vascular endothelial growth factor-a promotes peritumoral lymphangiogenesis and lymphatic metastasis [ J ]. Cancer Res, 2005,65 (20) :9261-9268.
  • 4潘旭峰,包国良,方文涛,陈文虎.血管内皮生长因子-C mRNA的表达与食管鳞癌临床病理特征的关系[J].中华肿瘤杂志,2008,30(6):437-440. 被引量:7
  • 5蒋明,勾红峰,杨雨,曹丹,侯梅.食管鳞癌中VEGF-C、VEGF-D的表达与临床病理特征的相关性研究[J].四川大学学报(医学版),2009,40(2):240-244. 被引量:9
  • 6Abdollahi A, Hahnfeldt P, Maereker C, et al. Endostatin, santiangiogenic signaling network [ J ]. Mol Cell, 2004,13 ( 5 ) :649-663.
  • 7Kuroi K, Tanaka C, Toi M. Circulating levels of endostatin in cancer patients[ J]. Oncol Reports, 2001,8 (2) : 405-409.
  • 8Gitay-Goren H, Soker S, Vlodavsky I, et al. The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules[ J ]. J B iol Chem, 1992,267 (9) :6093-6098.

二级参考文献23

  • 1Bustin SA. Absolute quantification of mRNA using real-time revere transcription polymerase chain reaction assays. J Mol Endocrinol, 2000, 25:169-193.
  • 2Noguchi T, Takeno S, Shibata T, et al. VEGF-C expression correlates with histological differentiation and metastasis in squamous cell carcinoma of the esophagus. Oncol Rep, 2002, 9:995-999.
  • 3Kimura Y, Watanabe M, Ohga T, et al. Vascular endothelial factor C expression correlates with lymphatic involvement and poor prognosis in patients with esophageal squamous cell carcinoma. Oncol Rep, 2003, 10:1747-1751.
  • 4Hofstetter W, Correa AM, Bekele N, et al. Proposed modification of nodal status in AJCC esophageal cancer staging system. Ann Thorac Surg, 2007, 84:365-373.
  • 5Daly JM, Fry WA, Little AG, et al. Esophageal cancer: results of an American College of Surgeons Patient Care Evaluation Study. J Am Coll Surg,2000,190(5) :562-573.
  • 6Soslow RA,Dannenberg AJ,Rush D,et al. Cox-2 is expressed in human pulmonary, colonic, and mammary tumors. Caneer, 2000;89(12):2637-2645.
  • 7Ohno M, Nakamura T, Kunimoto Y, et al. Lymphangiogenesis correlates with expression of vascular endothelial growth factor-C in colorectal cancer. Oncology Reports,2003, 10(4) :939-943.
  • 8Vleugel MM, Bos R, van der Groep P, et al. Lack of lymphangiogenesis during breast carcinogenesis. J Clin Pathol, 2004,57(7):746-751.
  • 9Choi WW, Lewis MM, Lawson D, et al. Angiogenic and lymphangiogenic microvessel density in breast carcinoma: correlation with clinicopathologic parameters and VECF-family gene expression. Mod Pathol,2005, 18(1) : 143-152.
  • 10Franehi A, Gallo O, Massi D,et al. Tumor lymphangiogenesis in head and neck squamous celt carcinoma: a morphometrie study with clinical correlations. Cancer, 2004,102(5) :973-978.

共引文献14

同被引文献19

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部